Power Life Sciences Inc.
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in bile duct cancer clinical trials, as well as the reasons for withdrawal or discontinuation. The insights gained from this study will ultimately benefit those with bile duct cancer who may be invited to participate in medical research in the years to come.
Bile Duct Cancer
| Study Type : | Observational |
| Estimated Enrollment : | 500 participants |
| Official Title : | Prospective Evaluation of Clinical Study Experiences of Patients With Bile Duct Cancer |
| Actual Study Start Date : | February 2024 |
| Estimated Primary Completion Date : | February 2025 |
| Estimated Study Completion Date : | February 2026 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.